At the RNA Institute, we focus on developing tools and analytics for moving RNA therapeutics down the drug candidate pathway. We disseminate these tools and technologies through collaborations with researchers in a breadth of disciplines and disease focuses, critical to human health.
RNA Institute Researcher Arun Richard Chandrasekaran recently published an article in Trends in Biomedical Sciences entitled “DNA Nanocarriers: Programmed to Deliver.” In this review, Dr. Chandrasekaran and his co-authors discuss the strategies used to transform DNA nanostructures into drug delivery … Continued
The 6th Annual RNA Symposium, The Language of RNA in Disease and Development, will be held at the University at Albany from March 21-22, 2019.
Dr. Andrew Berglund recently published new research with clinical significance for myotonic dystrophy (DM) therapies
RNA Institute Director, Dr. Andrew Berglund is attending the Myotonic Dystrophy Foundation’s 2018 Annual Conference on September 14-15 to present new research with clinical significance for myotonic dystrophy (DM) therapies. Dr. Berglund will be presenting his lab’s progress on developing … Continued
Professor J. Andrew Berglund will join the College of Arts and Sciences as Director of the RNA Institute and Professor of Biological Sciences in the Fall of 2018
The Hunt to End Disease ALBANY, N.Y. (March 8, 2018) – UAlbany chemists Max Royzen and Jia Sheng want to better understand how our body’s ribonucleic acid (RNA) can help fight some of the most challenging human diseases such as … Continued